NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0710
-0.0040 (-5.33%)
At close: Mar 27, 2026
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 23.61 million as of March 27, 2026. Its market cap has increased by 341.33% in one year.
Market Cap
23.61M
Enterprise Value
17.26M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 23.61M, an increase of 42.63%. That is a compound annual growth rate of 4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 23.61M | -35.45% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 56.78M |
| Imugene | 51.77M |
| Entropy Neurodynamics | 48.52M |
| Proteomics International Laboratories | 47.90M |
| EZZ Life Science Holdings | 41.18M |
| Avecho Biotechnology | 34.90M |
| Algorae Pharmaceuticals | 27.47M |
| Argenica Therapeutics | 21.20M |